Immunotherapy toxicities: An SGO clinical practice statement.

Competing Interests: Declaration of Competing Interest Dr. O'Cearbhaill reports honoraria from GSK, Bayer, Regeneron, Immunogen, MJH, SeaGen, Fresenius Kabi, and Curio, all outside the submitted work. Dr. Eskander reports grants and personal fees from AstraZeneca, personal fees from Myriad, personal fees from GOG Partners, grants and personal fees from Clovis Oncology, personal fees from GSK/Tesaro, personal fees from Merck, grants from Genentech Roche, personal fees from Iovance, all outside the submitted work. Dr. Gaillard reports grants from Abbvie, grants from Pfizer, grants from PharmaMar, grants from Iovance, grants from Tesaro, grants from Genentech/Roche, grants from Rigel, grants and personal fees from AstraZeneca, personal fees from Immunogen, personal fees from Sermonix, personal fees from Elevar Therapeutics, all outside the submitted work. In addition, Dr. Gaillard has a patent US 16/341,033 licensed, and a patent PCT/US2019/026669 licensed. All other authors have nothing to disclose.